Vir Biotechnology, Inc. (VIR)

NASDAQ: VIR · Real-Time Price · USD

10.47

+0.06 (0.58%)

At close: Oct 15, 2026, 4:00 PM EDT

10.50

+0.03 (0.29%)

After-hours: Oct 15, 2026, 7:57 PM EDT

Vir Biotechnology Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	303.23	68.56	74.21	86.18	1,616	1,095
Revenue Growth	1495.93%	-7.61%	-13.89%	-94.67%	47.50%	1334.39%
Gross Profit	-180.09	-375.95	-418.59	-486.65	994.83	581.54
Operating Income	-279.47	-468.02	-537.62	-661.09	833.07	420.75
Net Income	-251.68	-437.99	-521.96	-615.06	515.84	528.58
Earnings Per Share	-1.70	-3.16	-3.83	-4.59	3.83	3.96
EPS Growth	-	-	-	-	-3.28%	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	239.91	2.04	11.53	47.14	39.7	1,095
Foreign	63.31	66.52	62.68	39.04	1,576	-
Total	303.23	68.56	74.21	86.18	1,616	1,095

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	532.73	467.02	905.35	1,522	2,402	708.15
Total Debt	93.27	97.85	97.89	124.54	127.97	137.49
Net Cash (Debt)	439.45	369.16	807.46	1,398	2,274	570.66
Net Cash Growth	-12.77%	-54.28%	-42.24%	-38.53%	298.50%	-14.40%
Net Cash Per Share	2.96	2.67	5.93	10.42	16.87	4.28

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-202.51	-391.78	-446.35	-778.79	1,663	-47.59
Capital Expenditures	-1.09	-4.83	-7.3	-21.57	-68.01	-21.82
Free Cash Flow	-203.59	-396.61	-453.65	-800.36	1,595	-69.41
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-59.39%	-	-	-	61.57%	53.09%
Operating Margin	-92.16%	-682.68%	-724.51%	-767.10%	51.56%	38.41%
Pretax Margin	-82.87%	-638.56%	-704.95%	-728.93%	46.68%	50.19%
Profit Margin	-83.00%	-638.88%	-703.40%	-713.69%	31.92%	48.25%
FCF Margin	-67.14%	-578.52%	-611.35%	-928.71%	98.73%	-6.34%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	6.53	10.37
Forward PE	-	92.73	92.73	92.73	92.73	18.86
P/FCF Ratio	-	-	-	-	2.11	-
PS Ratio	5.84	12.24	13.62	15.70	2.09	5.00